Jove
Visualize
Contact Us

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.4K
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

434
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
434
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

67
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
67
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

457
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
457
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

81
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
81
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

51
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
51

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Ordered Ni<sub>6</sub> -Ring Superstructure Enables a Highly Stable Sodium Oxide Cathode.

Advanced materials (Deerfield Beach, Fla.)·2019
Same author

Sensitive and Selective Carmine Acid Detection Based on Chemiluminescence Quenching of Layer Doubled Hydroxide-Luminol-H<sub>2</sub>O<sub>2</sub> System.

ACS omega·2019
Same author

Elucidating Energy Pathways through Simultaneous Measurement of Absorption and Transmission in a Coupled Plasmonic-Photonic Cavity.

Nano letters·2019
Same author

Artificial Solid-Electrolyte Interface Facilitating Dendrite-Free Zinc Metal Anodes via Nanowetting Effect.

ACS applied materials & interfaces·2019
Same author

Revealing Insights into Li<sub></sub>FePO<sub>4</sub> Nanocrystals with Magnetic Order at Room Temperature Resulting in Trapping of Li Ions.

The journal of physical chemistry letters·2019
Same author

Spontaneous cellular vibratory motions of osteocytes are regulated by ATP and spectrin network.

Bone·2019
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 13, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.2K

Modeling Treatment Sequences in Pharmacoeconomic Models.

Ying Zheng1, Feng Pan2, Sonja Sorensen3

  • 1Evidera, 7101 Wisconsin Avenue, Suite 1400, Bethesda, MD, 20814, USA.

Pharmacoeconomics
|October 11, 2016
PubMed
Summary

Modeling treatment sequences in health economic models is crucial as interventions grow. This review guides conceptualizing and modeling sequences for optimal treatment strategies, addressing challenges like data scarcity.

More Related Videos

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Related Experiment Videos

Last Updated: Mar 13, 2026

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.2K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

17.2K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Area of Science:

  • Health Economics
  • Health Technology Assessment (HTA)

Background:

  • Increasingly complex therapeutic areas necessitate evaluating treatment sequences, not just individual interventions.
  • Health Technology Assessment (HTA) decision questions evolve to include optimal sequencing and placement of new treatments.

Purpose of the Study:

  • To review existing approaches for modeling treatment sequences in health economic models.
  • To provide practical guidance on conceptualizing and implementing treatment sequence modeling.

Main Methods:

  • Review of 40 economic models incorporating treatment sequencing, assessed by the National Institute for Health and Care Excellence.
  • Categorization of models by disease area and modeling technique (discrete event simulation, state-transition models, decision trees).

Main Results:

  • Cohort state-transition models with tracking states were the most common technique (28 models).
  • Sequencing was primarily incorporated to reflect clinical practice, trial design, or evaluate new treatment placement.
  • Key considerations for modeling include treatment options, patient heterogeneity, outcomes, and event risk.

Conclusions:

  • Treatment sequence modeling is essential for HTA with expanding therapeutic options.
  • Challenges remain, particularly the scarcity of clinical data evaluating different treatment sequences.
  • Guidance on modeling approaches can improve decision-making in complex treatment landscapes.